Inventor · disambiguated record
Sriram Naganathan
Also filed as: NAGANATHAN SRIRAM
9 granted patents·8 pending applications·92 citations·filing 2008–2024
87Inventor score
Top patents by PatentIndex Score
17 records- 0194US10159666B2Dosing of cabozantinib formulationsEXELIXIS INC·Filed 2015·Granted Dec 25, 2018·21 cites·8 claims
- 0293US9969692B2Process for preparing quinoline derivativesEXELIXIS INC·Filed 2016·Granted May 15, 2018·21 cites·21 claims
- 0392US10273211B2Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamideEXELIXIS INC·Filed 2014·Granted Apr 30, 2019·17 cites·2 claims
- 0492US9365516B2Process for preparing quinoline derivativesEXELIXIS INC·Filed 2012·Granted Jun 14, 2016·27 cites·28 claims
- 0585US2024287002A1Metabolites of n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamideEXELIXIS INC·Filed 2024·Application pending·0 cites
- 0683US10239858B2Process for making compounds for use in the treatment of cancerEXELIXIS INC·Filed 2017·Granted Mar 26, 2019·3 cites·7 claims
- 0782US9771347B2Process for making compounds for use in the treatment of cancerEXELIXIS INC·Filed 2015·Granted Sep 26, 2017·3 cites·2 claims
- 0872US2021002228A1Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamideEXELIXIS INC·Filed 2020·Application pending·0 cites
- 0971US11414396B2Process for making compounds for use in the treatment of cancerEXELIXIS INC·Filed 2020·Granted Aug 16, 2022·0 cites·8 claims
- 1068US10793541B2Process for making compounds for use in the treatment of cancerEXELIXIS INC·Filed 2019·Granted Oct 6, 2020·0 cites·6 claims
- 1165US2025115551A1Synthesis of ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 1262US2020163954A1Dosing of Cabozantinib FormulationsEXELIXIS INC·Filed 2020·Application pending·0 cites
- 1361US2019218182A1Metabolites of N-(4-{[6,7-Bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamideEXELIXIS INC·Filed 2019·Application pending·0 cites
- 1456US2019076420A1Dosing of Cabozantinib FormulationsEXELIXIS INC·Filed 2018·Application pending·0 cites
- 1553US2018230100A1Processes for Preparing Quinoline DerivativesEXELIXIS INC·Filed 2018·Application pending·0 cites
- 1652US2013197230A1Methods of preparing quinoline derivativesWILSON JO ANN·Filed 2009·Application pending·0 cites
- 1746US8426415B2Human ADAM-10 inhibitorsNAGANATHAN SRIRAM·Filed 2008·Granted Apr 23, 2013·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Sriram Naganathan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →